Review
Open access
Aug 2026
Personalized Anticoagulation in Cancer Patients: Current Evidence and Future Perspectives
Background and Objectives: Cancer-associated thrombosis (CAT) is still a leading cause of morbidity and mortality in patients with malignancy and represents a major challenge in cardio-oncology. Although low-molecular-weight heparins (LMWH) have long been the standard of care, direct oral anticoagulants (DOACs) have br...
Ștefan Chiorescu, M. Mocan, Bianca Patricia Dinică et al.
· Medicina · 0 citations